We evaluated serial fecal microbiota transplant (FMT) by retention enema in patients with severe or severe/complicated Clostridoides difficile infection (CDI) unresponsive to at least 48 hours of standard antibiotic therapy. Of the 15 patients included, despite initial improvement in most patients, only 5 patients sustained cure at 30 days, and serious adverse events occurred in 4 patients.

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciab041DOI Listing

Publication Analysis

Top Keywords

severe severe/complicated
8
severe/complicated clostridoides
8
clostridoides difficile
8
difficile infection
8
fecal microbiota
8
microbiota transplant
8
retention enema
8
patients
5
management severe
4
infection sequential
4

Similar Publications

Context: Diabetes is a chronic disease associated with many complications. Approximately 20% of people living with diabetes suffer from some form of depression. "Diabetes distress" (DD) is used to describe the significant negative psychological reactions related to emotional burdens and worries specific to an individual's experience to manage severe, complicated chronic disease such as diabetes.

View Article and Find Full Text PDF
Article Synopsis
  • A 25-year-old woman with fever and urinary issues was treated for a urinary tract infection but her condition worsened, leading to her hospitalization for high fever and leg weakness.
  • Initial lab tests indicated hemolytic anemia and acute kidney injury, but after discovering her recent trip to Africa, a malaria test confirmed she had Plasmodium falciparum with a high level of infection.
  • Despite receiving prompt treatment for malaria, she developed septic shock and required extensive medical interventions, highlighting the importance of thorough patient history in diagnosing complex illnesses.
View Article and Find Full Text PDF

Infective endocarditis is a rare disease in children. The etiology is mainly bacterial. However, viral infective endocarditis, possibly related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has also been reported.

View Article and Find Full Text PDF

Severely complicated ear infection in a patient treated with ixekizumab: a case report.

Eur Arch Otorhinolaryngol

October 2024

Department of Otorhinolaryngology-Head and Neck Surgery, ENT Resident, University Hospitals Leuven, Leuven, 3000, Belgium.

We report a case of a severe ear infection in a 35-year-old man treated with ixekizumab for psoriasis. Ixekizumab is a humanized monoclonal antibody that selectively prevents the interaction between interleukin 17 A and its receptor. Biologicals like ixekizumab are used to achieve symptom relief in autoimmune diseases including psoriasis.

View Article and Find Full Text PDF

Background: Although vancomycin is typically employed against methicillin-resistant Staphylococcus aureus (MRSA) infections, the optimal ratio of 24-h area under the concentration-time curve to minimum inhibitory concentration (AUC/MIC) for severe or complicated infections lacks clear guideline recommendations. This study aimed to determine the target AUC/MIC ratio associated with treatment outcomes of infections treated with vancomycin.

Methods: This retrospective multicenter cohort study included adult patients receiving ≥ 5 days of vancomycin for severe/complicated MRSA infections (e.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!